PMC:7200337 / 42998-43367
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T430 | 134-139 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T274 | 150-158 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T556 | 132-139 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
| T557 | 175-184 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
| T558 | 201-202 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T227 | 288-290 | Chemical | denotes | PD | http://purl.obolibrary.org/obo/CHEBI_74756 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1417 | 12-16 | Gene | denotes | GZMA | Gene:3001 |
| 1418 | 18-22 | Gene | denotes | GZMB | Gene:3002 |
| 1419 | 28-32 | Gene | denotes | GZMK | Gene:3003 |
| 1420 | 57-62 | Gene | denotes | KLRC1 | Gene:3821 |
| 1421 | 67-71 | Gene | denotes | XCL1 | Gene:6375 |
| 1451 | 297-302 | Gene | denotes | TIM-3 | Gene:84868 |
| 1457 | 164-166 | Gene | denotes | to | Gene:6999 |
| 1459 | 150-158 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1460 | 352-364 | Disease | denotes | cytotoxicity | MESH:D064420 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T231 | 120-365 | Sentence | denotes | In summary, T cells in severe COVID-19 seem to be more activated and may exhibit a trend toward exhaustion based on continuous expression of inhibitory markers such as PD-1 and TIM-3 as well as overall reduced polyfunctionality and cytotoxicity. |